Explore tweets tagged as #ClavystBio
Singapore’s ClavystBio is betting big on AI to unlock medical breakthroughs — aiming to 3× returns in life-science startups. The future of health is being coded now. #AIinHealthcare #Biotech #Singapore #ClavystBio #LifeSciences #FutureOfMedicine Source: https://t.co/fjknjccCrT
1
0
1
Singapore’s biotech sector is more successful than people think https://t.co/ZXv16bL8eF
#Premium_Content #Allay_Therapeutics #bioscience #Biotech #ClavystBio
0
0
0
🏢 Allay Therapeutics 📍 San Jose, United States of America 🏗️ Healthcare & Life Sciences 💰 $57.5M Series D 🤝 Investors: NEA, Vertex Growth, Vertex Ventures Healthcare, Brandon Capital, Lightstone Ventures, Arboretum Ventures, ClavystBio (Anselm Tan) 💰 undisclosed venture
0
0
0
Automera secures $16M in Series A funding co-led by ALSP, ClavystBio https://t.co/5VfjmaF8Bp
#automera
0
0
0
Fuelled by a deep sense of purpose, ClavystBio COO Michelle Evaristo has championed Temasek’s commitment to nurture promising biotech ideas. Go behind the scenes of its vision to transform healthcare’s future. https://t.co/breqte5ZrQ
#50byFifty #Temasekturns50 #T50 #Temasek
2
0
3
ClavystBio and A*STAR partner to grow MedTech Ventures in Singapore #astar #clavystbio
https://t.co/JJrRnmluEP
0
0
0
🏢 Leyden Labs 📍 Leiden, Netherlands 🏗️ Healthcare & Life Sciences 💰 $70.0M equity 🤝 Investors: Bluebird Ventures, Softbank, Invus, ClavystBio (Khoo Shih), Qiming Venture Partners, Polaris Partners, GV, Casdin Capital, F-Prime Capital, Byers Capital (Brook Byers) 🔗
0
0
1
Temasek’s ClavystBio, Lightstone Ventures back Allay Therapeutics’ $57.5M Series D financing #allaytherapeutics
https://t.co/SQ2UiqRKcm
0
0
0
Singapore’s Respiree closes $11.6M Series A financing round led by We Venture Capital and ClavystBio #respiree
https://t.co/KMDdgbhCpP
0
0
0
ClavystBio and A*STAR Partner to Grow MedTech Ventures in Singapore【ClavystBio】 https://t.co/p2ioWf3lZv
1
0
0
Biotechnology firm Automera raised $16 M Series A funding from ALSP, ClavystBio - https://t.co/jVWLt91POU
0
0
0
Biotech Startup Automera Raises $16 Million in Series A Round Led by ALSP and ClavystBio
0
0
0
ClavystBio backs $11.6m round for SG healthtech firm Respiree
0
0
0
Investors include EDB Investments and Temasek’s ClavystBio https://t.co/2cmF5qpDgk
0
0
0
ClavystBio co-anchors $11.6m funding in healthtech Respiree
0
0
0
ClavystBio, our biotech platform, has unveiled Node 1 in Singapore. Spanning 13,000 sq ft, the new research and collaboration centre will serve as a hub for biotech startups and will bolster the global journey of their local life science breakthroughs.
1
1
2
Temasek-backed ClavystBio co-leads Allay Therapeutics' Series D
0
0
0
Lightstone Ventures, Temasek's ClavystBio support Allay Therapeutics' $57.5 M Series D funding https://t.co/Dev3L52oHZ
0
0
0
Singapore's Respiree closes $11.6M Series A financing round led by We Venture Capital and ClavystBiO
0
0
0
Singapore's Respiree closed $11.6 M Series A financing from We Venture Capital, ClavystBio https://t.co/V6GJBCPBST
0
0
0